Diabetes & Endocrinology News
- Reducing Albumin Improves Kidney and Heart Function
- Statin Use Remains Low for At-Risk Patients
- No Benefit of Levothyroxine in Heart Donors
- How Gender-Affirming Treatment Affects Erythrocytosis
- US Obesity Docs Expect Zepbound to Show Heart Benefit
- Launches of Novo Nordisk's Weight-Loss Drug Wegovy
- EU Watchdog Seeks More Safety Data From GLP-1 Drugmakers
- Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects
- Smoking Alters Salivary Microbiota
- Procedures May Ease Postmenopausal Pain Better Than Drugs
- AI Aids Type 2 Diabetes Insulin Dosing
- What Is the Dark Side of GLP-1 Receptor Agonists?
- Novo Nordisk Finds Compounded Wegovy Up to 33% Impure
- Late-Life Increases in Pulmonary Pressure, Hypertension
- ACG 2023 Low-Dose Aspirin: No Flares in Pregnant Patients With IBD
- DMARDs Linked to Reduced Thyroid Disease Incidence
- Insufficient Sleep Impairs Women's Insulin Sensitivity
- More Weight Loss With Mounjaro Than Ozempic: Data Analysis
- AANEM 2023 Novel Myasthenia Gravis Therapies Bring Opportunities
- Despite Effective Therapies, Fibroid Care Still Lacking
- Novo to Launch Wegovy in Asia With February Roll-Out in Japan
- Novo Invests $2.3 Billion in France for Obesity Drug Production
- Cyberattacks Challenge Canadian Health Information Systems
- Urine Test Identifies Endocrine Hypertension With Help From AI
- Should Physicians Go to Work When Sick?
- Even an Hour's Walk a Week Lowers Risk in Type 2 Diabetes
- Both Too Much and Not Enough Sleep Raises T2D Risk
- Apple Cider Vinegar, Fenugreek Best Herbal Remedies for T2D
- Jury Still Out on Stopping GLP-1 RAs Prior to Endoscopy
- UK's First Living Donor Uterus Transplant a Success
- As MOC Debate Heats Up, Cardiology Societies Weigh In
- Artificial Sweeteners Increase Cardiovascular Risk
- Firefighters Fight Fat With Mediterranean Diet Adoption
- A1c Not Linked to Postop Complications in Kids With Diabetes
- Biosimilars Comparable to Aflibercept in Macular Disease
- Only 1 in 4 Feel Fully Recovered Following COVID-19 Hospitalisation
- Call for Tighter LDL Targets for Highest Risk Patients